Exagen XGN

Exagen reports Q3 2026 financial results

Exagen (XGN) filed an 8-K with the SEC on Nov 10, 2026, 7:33 am ET. Source: the filing on SEC EDGAR.

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Revenue grew 7% to $18.4 million
  2. Net loss reduced by 12% to $6.3 million
  3. Adjusted EBITDA loss improved by 30%

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get an email when Exagen files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.